Chronic Pruritus Therapeutics Global Market Report 2025

Description

Chronic pruritus therapy refers to treatments designed to manage or relieve persistent itching (pruritus) that lasts for six weeks or more. Managing chronic pruritus involves a combination of therapies tailored to the underlying cause, with treatment adjustments based on the patient's response.

The main product types for chronic pruritus therapeutics include corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and other treatments. Corticosteroids are medications that reduce inflammation and itching by suppressing the immune system's response, making them effective for treating chronic pruritus and inflammatory skin conditions. These products are used for various conditions, including atopic dermatitis, allergic contact dermatitis, urticaria, and others. They are distributed through multiple channels, such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The chronic pruritus therapeutics market research report is one of a series of new reports from The Business Research Company that provides chronic pruritus therapeutics market statistics, including the chronic pruritus therapeutics industry global market size, regional shares, competitors with the chronic pruritus therapeutics market share, detailed chronic pruritus therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic pruritus therapeutics industry. This chronic pruritus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic pruritus therapeutics market size has grown strongly in recent years. It will grow from $10.17 billion in 2024 to $10.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to rising prevalence of chronic pruritus, rising demand for effective treatments, growing regulatory approvals, rise in product approvals, increase in industry participants' mergers, collaborations, and acquisitions.

The chronic pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.36 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising awareness, rise in atopic dermatitis, increasing focus on personalized medicine, increasing prevalence of dermatological conditions, growing patient population. Major trends in the forecast period include introducing innovative medicines, development of novel biologics and targeted therapies, technological advancements, integration of advanced drug delivery systems, collaborations between pharmaceutical companies and research institutions, digital health technologies including telemedicine.

The forecast of 7.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. dermatology care by inflating prices of neurokinin-1 receptor antagonists and antipruritic creams developed in France and Japan, resulting in prolonged suffering and higher specialty pharmacy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of atopic dermatitis is expected to drive the growth of the chronic pruritus therapeutics market. Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by symptoms such as redness, itching, dryness, and irritation. It commonly affects individuals with a family history of allergies, asthma, or hay fever. The increasing prevalence of atopic dermatitis can be attributed to factors such as genetic predisposition, environmental changes, lifestyle habits, the hygiene hypothesis, increased allergen exposure, and imbalances in the skin microbiome. Chronic pruritus therapeutics help alleviate the persistent itching associated with atopic dermatitis by targeting the underlying inflammatory pathways, reducing skin irritation, and enhancing patient comfort. For example, in 2022, the International Eczema Council reported that approximately 223 million people worldwide were living with atopic dermatitis, including 43 million children aged 1-4, emphasizing the condition's high prevalence in early childhood. As a result, the growing prevalence of atopic dermatitis is driving the expansion of the chronic pruritus therapeutics market.

Key companies in the chronic pruritus therapeutics market are focusing on developing innovative treatments, such as intravenous (IV) injection therapies, to improve treatment efficacy and provide quicker relief for patients. IV injections deliver medications such as antihistamines or corticosteroids directly into the bloodstream, offering fast relief from itching and inflammation. For example, in September 2023, Cara Therapeutics Inc., a U.S.-based company, announced that its partner company Maruishi Pharmaceutical Co. Ltd. received approval from Japan's Ministry of Health, Labour and Welfare for the Korsuva IV injection syringe. This treatment, aimed at pruritus in hemodialysis patients, showed significant improvements in itching scores compared to a placebo in Phase 3 clinical trials and was well-tolerated by patients. The approval also triggered a $1.5 million milestone payment to Cara Therapeutics under the terms of their licensing agreement with Maruishi.

In May 2024, Incyte Corporation, a U.S.-based biopharmaceutical company, acquired Escient Pharmaceuticals for $750 million. This acquisition aims to strengthen Incyte's Inflammation and Autoimmunity (IAI) pipeline by integrating innovative therapies targeting severe inflammatory diseases. Escient Pharmaceuticals is a U.S.-based biotechnology company specializing in therapeutics for uremic pruritus.

Major players in the chronic pruritus therapeutics market are Pfizer Incorporated, AbbVie Inc., Sanofi S.A., Novartis Aktiengesellschaft, GlaxoSmithKline plc, Toray Industries Inc., CSL Behring LLC, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Ipsen S.A., Incyte Corporation, Cipla Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Mallinckrodt Pharmaceuticals plc, Kissei Pharmaceutical Co. Ltd., Asana BioSciences LLC, Vanda Pharmaceuticals Inc., Dermavant Sciences Inc., Galderma Laboratories L.P., Cara Therapeutics Inc., Avior Bio Inc., Trevi Therapeutics Inc.

North America was the largest region in the chronic pruritus therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic pruritus therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic pruritus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pruritus therapeutics market consists of sales of capsaicin creams, jak inhibitors, systemic therapies, phototherapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pruritus Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic pruritus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic pruritus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic pruritus therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Corticosteroid; Antihistamine; Local Anesthetic; Counterirritant; Immunosuppressant; Calcineurin Inhibitors; Other Product Types
2) By Disease Type: Atopic Dermatitis; Allergic Contact Dermatitis; Urticaria; Other Disease Types
3) By Distribution Channel: Hospital Pharmacies; Drug stores And Retail Pharmacies; Online Providers
Subsegments:
1) By Corticosteroid: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
2) By Antihistamine: First-Generation Antihistamines; Second-Generation Antihistamines
3) By Local Anesthetic: Topical Local Anesthetics; Injectable Local Anesthetics
4) By Counterirritant: Menthol-Based Counterirritants; Camphor-Based Counterirritants
5) By Immunosuppressant: Systemic Immunosuppressants; Topical Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus-Based Therapy; Pimecrolimus-Based Therapy
7) By Other Product Types: Biologic Therapies; Emerging Novel Therapies
Companies Mentioned: Pfizer Incorporated; AbbVie Inc.; Sanofi S.A.; Novartis Aktiengesellschaft; GlaxoSmithKline plc; Toray Industries Inc.; CSL Behring LLC; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Ipsen S.A.; Incyte Corporation; Cipla Limited; H. Lundbeck A/S; Sumitomo Pharma Co. Ltd.; Mallinckrodt Pharmaceuticals plc; Kissei Pharmaceutical Co. Ltd.; Asana BioSciences LLC; Vanda Pharmaceuticals Inc.; Dermavant Sciences Inc.; Galderma Laboratories L.P.; Cara Therapeutics Inc.; Avior Bio Inc.; Trevi Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34013u

1. Executive Summary

2. Chronic Pruritus Therapeutics Market Characteristics

3. Chronic Pruritus Therapeutics Market Trends And Strategies

4. Chronic Pruritus Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Chronic Pruritus Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Pruritus Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Pruritus Therapeutics Market Growth Rate Analysis
5.4. Global Chronic Pruritus Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Pruritus Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Pruritus Therapeutics Total Addressable Market (TAM)

6. Chronic Pruritus Therapeutics Market Segmentation

6.1. Global Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroid
Antihistamine
Local Anesthetic
Counterirritant
Immunosuppressant
Calcineurin Inhibitors
Other Product Types
6.2. Global Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Other Disease Types
6.3. Global Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug stores And Retail Pharmacies
Online Providers
6.4. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Corticosteroids
Oral Corticosteroids
Injectable Corticosteroids
6.5. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Antihistamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Antihistamines
Second-Generation Antihistamines
6.6. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Local Anesthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Local Anesthetics
Injectable Local Anesthetics
6.7. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Counterirritant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Menthol-Based Counterirritants
Camphor-Based Counterirritants
6.8. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Systemic Immunosuppressants
Topical Immunosuppressants
6.9. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tacrolimus-Based Therapy
Pimecrolimus-Based Therapy
6.10. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologic Therapies
Emerging Novel Therapies

7. Chronic Pruritus Therapeutics Market Regional And Country Analysis

7.1. Global Chronic Pruritus Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Pruritus Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Pruritus Therapeutics Market

8.1. Asia-Pacific Chronic Pruritus Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Pruritus Therapeutics Market

9.1. China Chronic Pruritus Therapeutics Market Overview
9.2. China Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Pruritus Therapeutics Market

10.1. India Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Pruritus Therapeutics Market

11.1. Japan Chronic Pruritus Therapeutics Market Overview
11.2. Japan Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Pruritus Therapeutics Market

12.1. Australia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Pruritus Therapeutics Market

13.1. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Pruritus Therapeutics Market

14.1. South Korea Chronic Pruritus Therapeutics Market Overview
14.2. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Pruritus Therapeutics Market

15.1. Western Europe Chronic Pruritus Therapeutics Market Overview
15.2. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Pruritus Therapeutics Market

16.1. UK Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Pruritus Therapeutics Market

17.1. Germany Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Pruritus Therapeutics Market

18.1. France Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Pruritus Therapeutics Market

19.1. Italy Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Pruritus Therapeutics Market

20.1. Spain Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Pruritus Therapeutics Market

21.1. Eastern Europe Chronic Pruritus Therapeutics Market Overview
21.2. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Pruritus Therapeutics Market

22.1. Russia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Pruritus Therapeutics Market

23.1. North America Chronic Pruritus Therapeutics Market Overview
23.2. North America Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Pruritus Therapeutics Market

24.1. USA Chronic Pruritus Therapeutics Market Overview
24.2. USA Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Pruritus Therapeutics Market

25.1. Canada Chronic Pruritus Therapeutics Market Overview
25.2. Canada Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Pruritus Therapeutics Market

26.1. South America Chronic Pruritus Therapeutics Market Overview
26.2. South America Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Pruritus Therapeutics Market

27.1. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Pruritus Therapeutics Market

28.1. Middle East Chronic Pruritus Therapeutics Market Overview
28.2. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Pruritus Therapeutics Market

29.1. Africa Chronic Pruritus Therapeutics Market Overview
29.2. Africa Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Pruritus Therapeutics Market Competitive Landscape And Company Profiles

30.1. Chronic Pruritus Therapeutics Market Competitive Landscape
30.2. Chronic Pruritus Therapeutics Market Company Profiles
- 30.2.1. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Pruritus Therapeutics Market Other Major And Innovative Companies

31.1. Toray Industries Inc.
31.2. CSL Behring LLC
31.3. Regeneron Pharmaceuticals Inc.
31.4. Astellas Pharma Inc.
31.5. Ipsen S.A.
31.6. Incyte Corporation
31.7. Cipla Limited
31.8. H. Lundbeck A/S
31.9. Sumitomo Pharma Co. Ltd.
31.10. Mallinckrodt Pharmaceuticals plc
31.11. Kissei Pharmaceutical Co. Ltd.
31.12. Asana BioSciences LLC
31.13. Vanda Pharmaceuticals Inc.
31.14. Dermavant Sciences Inc.
31.15. Galderma Laboratories L.P.

32. Global Chronic Pruritus Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Pruritus Therapeutics Market

34. Recent Developments In The Chronic Pruritus Therapeutics Market

35. Chronic Pruritus Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Chronic Pruritus Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Pruritus Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Pruritus Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer